Nexalin Technology (NXL) Operating Expenses (2021 - 2026)
Nexalin Technology has reported Operating Expenses over the past 5 years, most recently at $2.6 million for Q4 2025.
- For Q4 2025, Operating Expenses fell 11.43% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $8.6 million, up 9.44%, while the annual FY2025 figure was $8.6 million, 9.44% up from the prior year.
- Operating Expenses for Q4 2025 was $2.6 million at Nexalin Technology, up from $2.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $2.9 million in Q4 2024 and troughed at $602494.0 in Q4 2021.
- A 5-year average of $1.5 million and a median of $1.5 million in 2023 define the central range for Operating Expenses.
- Biggest five-year swings in Operating Expenses: crashed 64.65% in 2022 and later soared 274.02% in 2023.
- Year by year, Operating Expenses stood at $602494.0 in 2021, then increased by 24.68% to $751174.0 in 2022, then skyrocketed by 118.3% to $1.6 million in 2023, then surged by 76.55% to $2.9 million in 2024, then fell by 11.43% to $2.6 million in 2025.
- Business Quant data shows Operating Expenses for NXL at $2.6 million in Q4 2025, $2.4 million in Q3 2025, and $1.7 million in Q2 2025.